Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingBlue Cross Blue Shield-OK advanced imaging Prior A…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedBlue Cross Blue Shield - OklahomaPolicy N/A

    Prior authorization list for advanced imaging/radiology CPT/HCPCS codes

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Oklahoma policy alerts

    Know when Blue Cross Blue Shield - Oklahoma releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Lists CPT and HCPCS procedure codes for advanced imaging, molecular genetic, and select procedural services that may require prior authorization; identifies Carelon as the utilization manager for many listed codes and notes addition of site-of-care to medical necessity criteria effective 01/01/2025.

    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyPrior authorization list for advanced imaging/radiology CPT/HCPCS codes
    Policy CodePolicy N/A
    Change TypeAddition of site-of-care to medical necessitynew U-/T-codes added
    Effective Date01/01/2025
    Next Review DateN/A
    Key ActionSubmit prior authorization and required medical necessity documentation to the assigned manager (primarily Carelon) when ordering listed codes.
    SourceLink
    POLICY UPDATE CHANGES

    Addition of site of care to the medical necessity criteria for numerous advanced imaging/radiology codes effective 01/01/2025.

    Effective 01/01/2025, addition of site of care to the medical necessity criteria for multiple advanced imaging CPT codes.

    Multiple new molecular genetic test HCPCS U-codes (e.g., 0554U, 0555U, J0560U, 0561U, 0562U, 0565U, etc.) are being added effective 10/01/2025.

    Cytogenomic optical genome mapping code 81195 added effective 04/01/2025.

    Multiple new molecular genetic and related lab codes (0487U–0544U, etc.) and musculoskeletal/spine codes (0627T–0630T, 20930–20939, 20974–20975, 22206–22210) are added with management assigned to Carelon and effective dates.

    01/01/2025
    Effective date for updates
    CarelonManaged-by vendor
    10/01/2025New U-code additions effective
    04/01/202581195 addition effective
    ~140+Molecular/genetic codes listed

    Coverage Criteria and Medical Necessity Updates

    Code listings and management assignments

    Code listings and management assignments — consolidated operational listing indicating which codes are managed and any update/retirement notes. Codes listed below are grouped by service area and reflect the management assignment (Carelon unless otherwise noted) and any effective updates or retirement dates present in source content. This is an operational code listing; refer to the managed-utilization program for specific prior authorization or medical necessity rules.

    ANY of the following

    • Advanced Imaging/Radiology codes (examples from listing): 70336; 70450; 70460; 70470; 70480; 70492; 70496; 70498; 70540; 70542; 70543; 70552; 70553; 70554; 70555; 71250; 73222; 73223; 73225; 73700; 73701; 73702; 74150; 74160; 74170; 74174; 74175; Managed By = Carelon; Updates: Effective 01/01/2025 addition of site-of-care to medical necessity criteria (where indicated).
    • Molecular Genetic Lab Testing and related U-codes/T-codes (examples from listing): 0554U; 0555U; J0560U; 0561U; 0562U; 0565U; 81193; 81194; 81195 (added effective 04/01/2025); 81200–81295 range entries; 81410–81437 range entries (panels with minimum gene content specified, e.g., 81410 requires ≥9 genes; 81430 requires ≥60 genes); various molecular codes including 0078U (Retire Effective 07/01/2025), 0079U, 0087U, 0088U, 0089U, 0238U, 0239U, J0242U, 0244U, 0363U, 0364U, 0368U, 0378U, 0379U, 0380U (Retire Effective 04/01/2025), 0388U, 0389U, 0428U (Retire Effective 04/01/2025), 0433U, 0434U, 0437U, 0438U, 0453U, 0454U, 0456U (Retire Effective 04/01/2025), 0460U, 0461U, 0487U (Add effective 07/01/2025), 0488U (Add effective 07/01/2025), 0489U (Add effective 07/01/2025), 0493U (Add effective 07/01/2025), 0627T–0630T (Add effective 10/01/2025), 0627T–0630T managed by Carelon; Managed By = Carelon except where blank in source; Updates: various add/retire dates as noted.
    • Operational notes: where source indicates 'Managed By = Carelon' the code is subject to Carelon-managed utilization management and may require prior authorization or meet medical necessity criteria managed by Carelon. Several codes include explicit retirement effective dates (e.g., 0078U retire 07/01/2025; 0380U retire 04/01/2025; 0428U retire 04/01/2025; codes noted to retire 04/01/2025 within the 81433/81436/related entries). Some panel codes specify minimum gene content required for coverage (e.g., 81410, 81430, 81432, 81434, 81435, 81437).

    Procedure and Test Code Listings

    Advanced Imaging / Nuclear & Cardiology (listed codes)mixed
    78582Pulmonary Ventilation (Eg Aerosol Or Gas) And Perfusion Imaging.
    78597Quantitative Differential Pulmonary Perfusion Including Imaging When Performed.
    78598Quantitative Differential Pulmonary Perfusion And Ventilation (Eg Aerosol Or Gas) Including Imaging When Performed.
    78600Brain Imaging Less Than 4 Static Views.
    78601Brain Imaging Less Than 4 Static Views; With Vascular Flow.
    78605Brain Imaging Minimum 4 Static Views.
    78606Brain Imaging Minimum 4 Static Views; With Vascular Flow.
    78608Brain Imaging Positron Emission Tomography (PET); Metabolic Evaluation.
    78609Brain Imaging Positron Emission Tomography (PET); Perfusion Evaluation.
    78610Brain Imaging Vascular Flow Only.
    1–10 of 149
    1/15

    What Providers Must Do

    Prior Authorization

    Obtain prior authorization when required

    Services listed in this file are associated with CPT/HCPCS codes for which prior authorization may be required as of January 1, 2025; providers must obtain prior authorization where required prior to rendering services.

    Prior Authorization

    Follow Carelon prior-auth process and document site-of-care

    Prior authorization and utilization management for the listed CPT codes are managed by Carelon; medical necessity criteria were updated to add site-of-care effective 01/01/2025 — include site-of-care information in requests and follow Carelon processes.

    Prior Authorization

    Submit authorization to assigned manager

    Listed procedure, supply and molecular/genetic codes are assigned to a manager (Carelon or BCBSOK); submit prior authorization requests to the manager shown for each code and obtain approval before service.

    Prior Authorization and Utilization Management

    Prior Authorization

    Obtain authorization for advanced imaging effective 01/01/2025

    Effective 01/01/2025, prior authorization may be required for advanced imaging (CT, MRI, CTA, MRA) codes listed in this document; specific authorization requirements and site-of-care considerations are determined by Carelon.

    Prior Authorization

    Carelon-managed advanced imaging — follow Carelon UM

    Advanced imaging CPTs in the list are managed by Carelon; prior authorization and utilization management apply per Carelon processes and the updated site-of-care medical necessity criteria.

    Prior Authorization

    Obtain Carelon authorization for listed molecular genetic U‑codes

    The listed molecular genetic U‑codes and PLA codes are managed by Carelon; providers must obtain authorization/management through Carelon when ordering these lab-based molecular genetic tests.

    Contrast and Sequence Coding Notes

    Billing Rule

    Code according to performed contrast sequence

    Many CPT codes are provided in 'with' and 'without' contrast variants (or 'without followed by with'); code and bill according to the sequences actually performed and use the contrast-specific CPT variant when appropriate.

    Billing Rule

    Select contrast-specific CPT code that matches performed sequences

    Where CPT descriptors include 'without contrast', 'with contrast', or 'without followed by with contrast', select the correct CPT code that matches the contrast sequences performed for the study.

    Billing Rule

    Bill the CPT/HCPCS variant matching the 'without followed by with' sequence

    Definitions and Term Notes

    Managed By (Carelon)
    Managed By = Carelon'Managed By' indicates the external utilization management organization responsible for prior authorization and claims review (Carelon for most listed codes)
    Provider actionSubmit prior authorization and utilization management requests to the manager indicated in the code entry (Carelon or BCBSOK)
    Site-of-care noteMedical necessity criteria updated to include site of care effective 01/01/2025; consult the manager's criteria for details
    Site of care
    Site of care added to medical necessitySite of care is now part of medical necessity criteria for many listed CPT codes effective 01/01/2025
    Operational impactSite-of-care considerations may affect where imaging is authorized (e.g., outpatient facility vs hospital outpatient)

    Covered Indications (as stated in document extracts)

    Imaging indications follow standard CPT descriptors; prior authorization and site-of-care considerations apply per managed criteria

    Imaging indications correspond to the standard CPT descriptors; prior authorization and site-of-care considerations apply per the assigned manager's criteria

    Standard CPT indications: Imaging procedure indications follow the anatomic/clinical descriptions in the CPT code descriptors; clinical appropriateness and prior authorization (including site-of-care) are determined by the managing organization (Carelon) per updated medical necessity criteria.

    Detailed indication-level criteria are maintained by Carelon and are not reproduced in this document segment.

    G0252 specified for PET imaging in diagnosis/surgical planning for breast cancer (initial staging of axillary lymph nodes)

    G0252 is the CPT/HCPCS entry specified for PET imaging in breast cancer diagnosis and surgical planning

    Breast cancer PET indication example: G0252: PET imaging full and partial-ring — diagnosis of breast cancer and/or surgical planning (e.g., initial staging of axillary lymph nodes).

    Frequency Limits and Related Notes

    Frequency limits
    Frequency limits placeholderNo explicit frequency limits found in cited chunks
    Actionable noteRefer to the managing vendor (Carelon) for any frequency/authorization rules not present in this file
    Claims implicationAbsence of frequency limits in this extract does not waive prior authorization where required
    Frequency limits (operational note)
    Frequency limits placeholderNo explicit frequency limits present in the inventory excerpt
    RecommendationProviders should consult Carelon criteria for frequency restrictions per code

    Not Covered / Exclusions

    The inventory identifies G0219 with the description "PET Imaging Whole Body; Melanoma For Non-Covered Indications". This labeling in the code list signals that there are non-covered indications associated with G0219, but the excerpt itself does not enumerate the specific non-covered clinical scenarios—those are defined elsewhere in payer or managed-vendor guidance.

    Chunk 48 shows the G0252/G0219 area of the listing and specifically records G0219 as "PET Imaging Whole Body; Melanoma For Non-Covered Indications." The document therefore flags G0219 as relating to non-covered indications, but detailed exclusion wording or the exact non-covered scenarios are not provided in this excerpt.

    Background and Scope

    This policy section enumerates advanced imaging and related procedure codes across body regions and modalities that are subject to utilization management. The listing highlights that many entries are Managed By = Carelon and that administrative updates—most notably the addition of site-of-care to medical necessity criteria effective 01/01/2025—apply to the listed advanced imaging/radiology CPT and HCPCS codes.

    Imaging entries use standard CPT descriptors for indications (e.g., CT head, MRI spine, PET) and include code-level variants for contrast sequencing. The document repeatedly notes that medical necessity criteria were updated to add site-of-care considerations effective 01/01/2025; however, this extract does not contain the full clinical appropriateness rules. Providers must follow the designated manager’s (Carelon) prior authorization and site-of-care policies when requesting authorization for the listed imaging services.

    Policy Update History

    2025-10-01addition

    Multiple new molecular genetic HCPCS U-codes (e.g., 0554U, 0555U, J0560U, 0561U, 0562U, 0565U) were added with effective date 10/01/2025 and are designated as managed by Carelon.

    2025-04-01addition

    CPT code 81195 (cytogenomic optical genome mapping for hematologic malignancy) was added effective 04/01/2025 and is designated as managed by Carelon.

    2025-01-01criteria_updateLatest
    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyPrior authorization list for advanced imaging/radiology CPT/HCPCS codes
    Policy CodePolicy N/A
    Change TypeAddition of site-of-care to medical necessitynew U-/T-codes added
    Effective Date01/01/2025
    Next Review DateN/A
    Key ActionSubmit prior authorization and required medical necessity documentation to the assigned manager (primarily Carelon) when ordering listed codes.
    SourceLink
    On This Page
    Coverage Criteria and Medical Necessity UpdatesProcedure and Test Code ListingsWhat Providers Must DoPrior Authorization and Utilization ManagementContrast and Sequence Coding NotesDefinitions and Term NotesCovered Indications (as stated in document extracts)Frequency Limits and Related NotesNot Covered / ExclusionsBackground and ScopePolicy Update History
    Prior Authorization

    Obtain Carelon authorization for Carelon-managed molecular tests

    The HCPCS U‑codes and molecular test entries identified as 'Managed By = Carelon' require prior authorization per Carelon's utilization management process; providers must follow Carelon's authorization procedures when ordering these molecular tests.

    Prior Authorization

    Route prior-authorization requests to Carelon

    Many CPT codes in the list are marked 'Managed By = Carelon' — prior authorization or utilization management requests for those CPT codes should be routed to Carelon.

    Prior Authorization

    Carelon prior authorization for CPT 81307–81405

    The molecular genetic CPT codes in the 81307–81405 range are designated 'Managed By = Carelon' and are subject to the payer's utilization management — obtain prior authorization from Carelon for these molecular genetics procedures.

    Prior Authorization

    Carelon manages prior authorization for listed surgical/procedural CPTs

    Surgical and procedural CPT codes listed under musculoskeletal/spine categories (examples in the document) are managed by Carelon; prior authorization is required through Carelon per the management assignment.

    Prior Authorization

    CPT 27412 requires Carelon prior authorization

    Certain individual CPTs explicitly require prior authorization through Carelon; for example, CPT 27412 (Autologous Chondrocyte Implantation Knee) requires prior authorization through Carelon.

    Documentation Required

    Reference manager-specific (Carelon) medical necessity criteria

    Codes that list a managing organization include an 'Updates' note adding site-of-care to medical necessity; providers should reference the manager-specific (Carelon) medical necessity criteria when preparing authorization requests.

    Documentation Required

    Reference exact procedure code and service category on requests

    Claims and authorization submissions must reference the exact procedure code and service category as listed in the document to ensure routing to the correct manager and proper review.

    Documentation Required

    Document specific molecular CPT or U‑code and follow Carelon UM

    When submitting authorization or claims for molecular tests or U‑codes, document the specific CPT or U‑code being ordered and follow Carelon's utilization management documentation requirements for that code.

    Billing Rule

    Use correct code effective dates and follow Carelon management

    Submit claims and prior-authorization requests using the correct code effective date; many new U‑codes and T‑codes have specific add/effective dates (e.g., U‑codes effective 10/01/2025, 81195 effective 04/01/2025) and are managed by Carelon.

    Prior Authorization

    Carelon-managed molecular genetic CPTs require authorization

    All listed CPT molecular genetic test codes (CPT 81307–81405) and related entries are managed by Carelon; obtain prior authorization and follow Carelon's utilization management procedures for these laboratory services.

    Prior Authorization

    Carelon manages 0627T–0630T (effective 10/01/2025) — obtain authorization

    Interventional spine codes 0627T–0630T for percutaneous allogeneic disc injection are managed by Carelon with an add-effective date of 10/01/2025; follow Carelon authorization processes when these services are billed on or after that date.

    Prior Authorization

    Route surgical/procedural prior-auth to Carelon

    Surgical and procedural CPT-coded interventions listed in the document are routed to Carelon for utilization management; submit prior authorization to Carelon as indicated for the specific procedure codes.

    Prior Authorization

    Follow Carelon UM for molecular/genetic lab testing

    The molecular/genetic lab testing entries and U‑codes in this document are designated 'Managed By = Carelon'; providers must follow Carelon's utilization management and prior-authorization processes for those tests.

    Examples in the list show codes with 'without followed by with contrast' sequences (e.g., 0635T/0638T and C8901→C8902 patterns); bill the CPT/HCPCS code variant that reflects the actual imaging sequence.

    Billing Rule

    Report echocardiographic contrast (CPT 93352) separately and follow Carelon

    Use of an echocardiographic contrast agent (CPT 93352) is listed as separately reportable and is managed by Carelon; submit authorization/documentation to the managing entity as required.

    Provider requirementInclude site-of-care information when submitting authorization per the managing vendor's criteria
    81195 (OGM) definition
    81195 description81195: Cytogenomic (genome-wide) analysis, hematologic malignancy, structural variants and copy number variants, optical genome mapping (OGM)
    Effective date81195 added effective 04/01/2025 (managed by Carelon)
    Service categoryListed under Molecular Genetic Lab Testing and managed by Carelon
    Molecular Pathology Procedure Levels (81400–81405)
    Molecular Pathology Procedure Levels81400–81405 represent increasing analytic complexity (level examples: single-variant methods through regionally targeted cytogenomic analysis)
    Level descriptions81400 level 1 = single germline variant detection; 81403–81405 describe progressively larger exon/gene analyses
    ManagementEntries for these levels are managed by Carelon per the listing
    Genomic Sequence Analysis Panel
    Genomic Sequence Analysis PanelMulti-gene panel testing requires minimum gene counts per panel CPT (examples: 81410 min 9 genes; 81413 min 10 genes; 81430 min 60 genes)
    DocumentationProviders must document that the ordered panel meets the minimum gene content for the indicated clinical disorder
    Managed ByPanels and their minimums are noted in entries managed by Carelon
    Carelon
    Carelon designated managerCarelon is the designated external utilization management organization for the listed molecular genetic lab testing codes
    Provider actionSubmit prior authorization and required documentation to Carelon for codes marked 'Managed By = Carelon'
    ScopeCarelon manages a broad set of CPT, HCPCS U-, and PLA-like codes listed in the document
    Percutaneous allogeneic disc injection (T-codes)
    Procedure descriptionPercutaneous injection of allogeneic cellular and/or tissue-based product into intervertebral disc (T-codes 0627T–0630T) with imaging guidance
    Effective date and management0627T–0630T added effective 10/01/2025 and are listed as 'Managed By = Carelon'
    Billing noteCodes list first level and additional-level reporting (additional levels billed separately)
    STR comparative analysis
    STR comparative analysisComparative short tandem repeat (STR) analysis compares patient and comparative specimens for identity/zygosity/contamination
    Additional specimen billing81266 is reported for each additional specimen (list separately) in STR comparative analysis
    Managed By81265/81266 entries are managed by Carelon per the listing

    Managed By = Carelon; prior authorization/UM processes apply.

    Cardiac imaging modalities listed without embedded clinical indication criteria in this fragment

    Cardiac imaging modalities are listed; clinical indication criteria and prior authorization are managed externally

    Cardiac imaging listing: Cardiac PET, myocardial perfusion PET, cardiac blood pool imaging, gated equilibrium, and echocardiography modalities are enumerated in the code list; this fragment does not embed detailed clinical appropriateness criteria.

    These entries are managed by Carelon for utilization review; providers should consult Carelon for indication-specific medical necessity rules.

    Percutaneous injection of allogeneic cellular/tissue product into intervertebral disc (0627T–0630T) — listed as new services managed by Carelon effective 10/1/2025

    New interventional spine codes for allogeneic disc injection are added with Carelon management effective 10/01/2025

    Allogeneic disc injection codes: Percutaneous injection of allogeneic cellular/tissue product into the intervertebral disc (0627T–0630T) were added effective 10/01/2025 and are managed by Carelon.effective 10/01/2025

    Prior authorization/ utilization management expected through Carelon beginning on the effective date.

    Documentation
    When frequency limits apply, include dates of prior similar services in authorization requests

    Addition of 'site of care' to the medical necessity criteria for numerous advanced imaging/radiology CPT codes, with the listed codes managed by Carelon, effective 01/01/2025.

    2025-10-01addition

    Several new HCPCS/PLA U-codes (including 0554U, 0555U, J0560U, 0561U, 0562U, 0565U) were added effective 10/01/2025 and are managed by Carelon.

    2025-04-01additionLatest

    CPT 81195 (cytogenomic genome-wide analysis using optical genome mapping) was added effective 04/01/2025 and is managed by Carelon.